Pharmaceutical and biotechnology company developing a new class of anti-cancer drugs with a novel mechanism of action: inhibition of the mTOR1/2 signalling pathways and induction of autophagy.
National Ranking1775th
in Spain Regional Ranking20165th
in Western Europe Global Ranking79756th
worldwide Rankings by
